Melanoma
A137 – A143
- A137: VEGFR1/PKCα signaling controls melanoma vasculogenic mimicry and is not dependent on VEGFR2 kinase
- A138: Abstract withdrawn
- A139: Characterisation of circulating melanoma cells in patients with advanced disease
- A140: The effect of type 1 insulin-like growth factor receptor (IGF1R) signalling on sensitivity of melanoma cells to Temozolomide (TMZ)
- A141: CCL21 neutralising antibody as a potential inhibitor of metastatic chemotaxis
- A142: Effects of beta-catenin, LEF-1, c-jun and PEA 3 on Osteopontin expression in Malignant Melanoma
- A143: A study of melanoma patients in Phase I clinical trials: looking beyond the established
